Mandate

Vinge advises the founders of Future Media Group in conjunction with the sale to Caybon

Vinge has advised the founders Rikard Virta, Linus Wennerström and Johan Oscarsson as well as the other shareholders in conjunction with the sale of Future Media Group AB to Caybon.

Future Media Group specialises in helping media owners and growth companies to generate new revenue streams through business development, product development and sales. In close co-operation with its partners, new advertising formats, media solutions and marketing concepts are developed, and the solutions to the correct target groups are prepared in conjunction with the different sales organisations specialising in different types of products and customer segments.

Future Media Groups current partners currently include large media groups such as Bonnier and Stampen, as well as niche actors such as Preglife (the Nordic Region’s leading pregnancy app) and the digital veterinary service, Firstvet. The company has offices in Stockholm and Oslo and employs approximately 100 persons. 

Vinges team has primarily consisted of Jonas JohanssonCarl SanderEllinor Wargenbrant and Linus Adolfsson (M&A), as well as Sara Dahlros Sköld and Ellinore Boström Andersson (VDR).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025